Trials / Completed
CompletedNCT00938847
Bone Marrow Derived Mononuclear Cells For Myocardial Regeneration
Bone Marrow Derived Mononuclear Cells For Myocardial Regeneration in Early Left Ventricular Dysfunction After Acute Myocardial Infarction And Successful Percutaneous Coronary Intervention
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Asklepios proresearch · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Evaluative pilot study for safety and feasibility with administration of autologous bone bone marrow derived mononuclear cells by endoventricular catheter into the normal border zone fo the ischemic lesion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PCI | Stent implantation after acute myocardial infarction |
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2007-10-01
- Completion
- 2008-10-01
- First posted
- 2009-07-14
- Last updated
- 2009-07-14
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00938847. Inclusion in this directory is not an endorsement.